Shimadzu Scientific Instruments has launched the GCMS-QP2010 Ultra, which provides best-in-class performance for GC-MS analysis. The GCMS-QP2010 Ultra is capable of fast data measurement with sensitivity five times higher than previous models.
Pharmaceutical companies in the Asia Pacific region are increasingly adapting their business models from the production of generic drugs towards more high-risk, high-return research and development, according to a new report released by CMR International.
Affymetrix will contribute genotyping data for a large set of validated rare and common genomic variants to the 1000 Genomes Project. This powerful data consists of genotyping information from more than 2 million single nucleotide polymorphisms.
Provectus Pharmaceuticals, Inc., an oncology and dermatology biopharmaceutical company, presented positive preliminary data from fully monitored study data for the entire study population in its Phase 2 clinical trial of PV-10 for metastatic melanoma.
Eli Lilly and Company announced that the U.S. Food and Drug Administration has approved Cymbalta for the management of chronic musculoskeletal pain. This has been established in studies in patients with chronic low back pain and chronic pain due to osteoarthritis.
Scientists have eliminated a debilitating side effect associated with one of the main chemotherapy drugs used for treating colon cancer. By inhibiting an enzyme in bacteria of the digestive tract, patients can receive higher and more effective doses of irinotecan.
There are disorders and conditions that entail increased itching and can be extremely troublesome for those suffering from it. The mechanisms behind itching are not well understood today. For one thing, what is it about scratching that relieves itching?
Researchers have identified a gene linked to the spread of eye melanoma. Although more research is needed, the researchers say the discovery is an important step in understanding why some tumors spread and others don't.
Genetic diseases impact millions around the world each and every day. Susceptibility to hypertension has many genetic components and often goes undiagnosed until a person has signs of advanced disease.
Illumina, Inc. announced TruSeq sample preparation kits for DNA, RNA, and small RNA applications and the TruSeq Exome Enrichment Kit, for use across the company’s portfolio of sequencing platforms.
Olympus has introduced two microscopes to its leading BX3 series: the BX53 Motorized Advanced Research Microscope and BX43 Motorized Clinical and Research Microscope. The new microscope stands can be customized to meet users' specific needs.
bitop AG, a biotech company specializing in the development of Ectoin-containing medical devices, announced the inclusion of the first patient into a clinical trial on the Ectoin inhalation solution in patients with inflammation and airway obstruction.
Sigma Life Science and The Jackson Laboratory, a not-for-profit genetics research institution, announced a joint agreement allowing JAX to distribute mouse models created using Sigma Life Science’s proprietary zinc finger nuclease technology.
Scientists have taken an important step toward a better understanding of prostate cancer by uncovering evidence that it is not one disease, but rather several factors which can be measured and, in the future, destroyed by targeted therapy.
Researchers at the University of Cincinnati and the Cincinnati Veterans Affairs Medical Center have found that about one-third of chronic kidney disease patients who are prescribed therapies for high blood pressure do not often adhere to treatments.